ImmunoGen (NASDAQ:IMGN) Research Coverage Started at StockNe

StockNews.com started coverage on shares of ImmunoGen (NASDAQ:IMGN – Free Report) in a research note issued to investors on Monday. The firm issued a hold rating on the biotechnology company’s stock. A number of other brokerages have also weighed in on IMGN. Piper Sandler restated a neutral rating and set a $31.00 price target (up […]

Related Keywords

Blackrock , New Zealand General , New Zealand , Wellington , William Blair , Theresa Wingrove , Piper Sandler , Securities Exchange Commission , Immunogen Inc , Barclays , Jefferies Financial Group , Wellington Management Group , Blackrock Inc , Vanguard Group Inc , Free Report , Financial Group , Exchange Commission , Street Corp , Management Group , Get Free Report , Immunogen Daily , Immunogen , Nasdaq Imgn , Imgn , Medical , 45253h10 , Initiated Coverage , Stocknews Com ,